Unusual types of α Thalassemia

Disorders of Hemoglobin: Genetics, Pathophysiology, and Clinical Management, Second Edition

Volumn , Issue , 2009, Pages 296-320

  Higgs, Douglas R ^a   Buckle, Veronica J ^b   Gibbons, Richard ^b   Steensma, David ^c  

^a MRC Molecular Haematology Unit   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77952302514     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511596582.021     Document Type: Chapter

References (119)

1. Weatherall DJ, Higgs DR, Bunch C, et al. Hemoglobin H disease and mental retardation. A new syndrome or a remarkable coincidence? NEngl J Med. 1981;305:607-612.
2. Wilkie AOM, Buckle VJ, Harris PC, et al. Clinical features and molecular analysis of the α thalassaemia/mental retardation syndromes. I. Cases due to deletions involving chromosome band 16p13.3. AmJ Hum Genet. 1990;46:1112-1126.
3. Wilkie AOM, Zeitlin HC, Lindenbaum RH, et al. Clinical features and molecular analysis of the α thalassemia/mental retardation syndromes. II. Cases without detectable abnormality of the α globin complex. Am J Hum Genet. 1990;46: 1127-1140.
4. Schmickel RD. Contiguous gene syndromes: a component of recognizable syndromes. J Pediatr. 1986;109:231-241.
5. Callen DF, Hyland VJ, Baker EG, et al.Mapping the short arm of human chromosome 16. Genomics. 1989;4:348-354.
6. Neidengard L, Sparkes RS. Ring chromosome 16. Hum Genet. 1981;59:175-177.
7. Quintana A, Sordo MT, Estevez C, Ludena MC, San Roman C. 16 Ring chromosome. Clin Genet. 1983;23:243.
8. Buckle VJ, Higgs DR, Wilkie AOM, Super M, Weatherall DJ. Localisation of human α globin to 16p13.3-pter. J MedGenet. 1988;25:847-849.
9. Lamb J, Wilkie AOM, Harris PC, et al. Detection of breakpoints in submicroscopic chromosomal translocation, illustrating an important mechanism for genetic disease. Lancet. 1989;ii:819-824.
10. Buckle VJ, Kearney L. New methods in cytogenetics. Curr Opin Genet Dev. 1994;4:374-382.
11. Brown J, Saracoglu K, Uhrig S, Speicher MR, Eils R, Kearney L. Subtelomeric chromosome rearrangements are detected using an innovative 12-color FISH assay (M-TEL). Nat Med. 2001;7:497-501.
12. Price TS, Regan R, Mott R, et al. SW-ARRAY:a dynamic programming solution for the identification of copy-number changes in genomic DNA using array comparative genome hybridization data. Nucl Acids Res. 2005;33:3455-3464.
13. Redon R, Ishikawa S, Fitch KR, et al. Global variation in copy number in the human genome. Nature. 2006;444:444-454.
14. Colella S, Yau C, Taylor JM, et al. QuantiSNP: an Objective Bayes Hidden-Markov Model to detect and accurately map copy number variation using SNP genotyping data. Nucl Acids Res. 2007;35:2013-2025.
15. Harteveld CL, Kriek M, Bijlsma EK, et al. Refinement of the genetic cause of ATR-16. Hum Genet. 2007;122:283-292.
16. Harteveld CL, Voskamp A, Phylipsen M, et al. Nine unknown rearrangements in 16p13.3 and 11p15.4 causing alpha-and beta-thalassaemia characterised by high resolution multiplex ligation-dependent probe amplification. J Med Genet. 2005;42:922-931.
17. Lamb J, Harris PC, Wilkie AOM, Wood WG, Dauwerse JG, Higgs DR. De novo truncation of chromosome 16p and healing with (TTAGGG)n in the α-thalassemia/mental retardation syndrome (ATR-16). Am J Hum Genet. 1993;52:668-676.
18. Daniels RJ, Peden JF, Lloyd C, et al. Sequence, structure and pathology of the fully annotated terminal 2 Mb of the short arm of human chromosome 16. Hum Mol Genet. 2001;10:339-352.
19. Horsley SW, Daniels RJ, Anguita E, et al. Monosomy for the most telomeric, gene-rich region of the short arm of human chromosome 16 causes minimal phenotypic effects. Eur J Hum Genet. 2001;9:217-225.
20. European Polycystic Kidney Disease Consortium. The polycystic kidney disease 1 gene encodes a 14 kb transcript and lies within a duplicated region on chromosome 16. Cell. 1994;77:881-894.
21. Vogel F, Motulsky AG. Human Genetics. Problems and Approaches. 2nd ed. Berlin: Springer-Verlag; 1986.
22. Hall JG. Genomic imprinting: review and relevance to human diseases. AmJ Hum Genet. 1990;46:857-873.
23. Schneider AS, Bischoff FZ, McCaskill C, Coady ML, Stopfer JE, Shaffer LG. Comprehensive 4-year follow-up on a case of maternal heterodisomy for chromosome 16. Am JMed Genet. 1996;66:204-208.
24. Fisher E, Scambler P. Human haploinsufficiency-one for sorrow, two for joy. Nat Genet. 1994;7:5-7.
25. Pfeifer D, Poulat F, Holinski-Feder E, Kooy F, Scherer G. The SOX8 gene is located within 700 kb of the tip of chromosome 16p and is deleted in a patient with ATR-16 syndrome. Genomics. 2000;63:108-116.
26. Flint J, Wilkie AOM, Buckle VJ, Winter RM, Holland AJ, McDermid HE. The detection of subtelomeric chromosomal rearrangements in idiopathic mental retardation. Nat Genet. 1995;9:132-140.
27. Wilkie AOM, Pembrey ME, Gibbons RJ, et al. The nondeletion type of α thalassaemia/mental retardation: a recognisable dysmorphic syndrome with X-linked inheritance. J MedGenet. 1991;28:724.
28. Gibbons RJ, Wilkie AOM, Weatherall DJ, Higgs DR. A newly defined X linked mental retardation syndrome associated with α thalassaemia. J MedGenet. 1991;28:729-733.
29. Carpenter NJ, Qu Y, Curtis M, Patil SR. X-linked mental retardation syndrome with characteristic "coarse" facial appearance, brachydactyly, and short stature maps to proximal Xq. Am J Med Genet. 1999;85:230-235.
30. Guerrini R, Shanahan JL, Carrozzo R, Bonanni P, Higgs DR, Gibbons RJ. A nonsense mutation of the ATRX gene causing mild mental retardation and epilepsy. Ann Neurol. 2000;47:117-121.
31. Yntema HG, Poppelaars FA, Derksen E, et al. Expanding phenotype of XNP mutations: mild to moderate mental retardation. Am J Med Genet. 2002;110:243-247.
32. Abidi FE, Cardoso C, Lossi AM, et al. Mutation in the 5ʹ alternatively spliced region of the XNP/ATR-X gene causes Chudley-Lowry syndrome. Eur J Hum Genet. 2005;13:176-183.
33. Wada T, Gibbons RJ. ATR-X syndrome. In: Fisch GS, ed. Genetics and Genomics of Neurobehavioral Disorders. Totowa, NJ: Humana Press; 2003:309-334.
34. Kurosawa K, Akatsuka A, Ochiai Y, Ikeda J, Maekawa K. Selfinduced vomiting in X-linked α-thalassemia/mental retardation syndrome. Am JMed Genet. 1996;63:505-506.
35. Wada T, Nakamura M, Matsushita Y, et al. [Three Japanese children with X-linked alpha-thalassemia/mental retardation syndrome (ATR-X)]. No To Hattatsu. 1998;30:283-289.
36. McPherson E, Clemens M, Gibbons RJ, Higgs DR. X-linked alpha thalassemia/mental retardation (ATR-X) syndrome. A new kindred with severe genital anomalies and mild hematologic expression. Am JMed Genet. 1995;55:302-306.
37. Gibbons RJ, Brueton L, Buckle VJ, et al. The clinical and hematological features of the X-linked α thalassemia/mental retardation syndrome (ATR-X). Am JMed Genet. 1995; 55:288-299.
38. Martucciello G, Lombardi L, Savasta S, Gibbons RJ. The gastrointestinal phenotype of ATR-X syndrome. Am JMed Genet. 2006;140:1172-1176.
39. Villard L, Gecz J, Mattel JF, et al. XNP mutation in a large family with Juberg-Marsidi syndrome. Nat Genet. 1996;12:359-360.
40. Villard L, Lacombe D, Fontes M. A point mutation in the XNP gene, associated with an ATR-X phenotype without α-thalassemia. Eur J Hum Genet. 1996;4:316-320.
41. Donnai D, Clayton-Smith J, Gibbons RJ, Higgs DR. The nondeletion α thalassaemia/mental retardation syndrome. Further support for X linkage. J Med Genet. 1991;28:742-745.
42. Gibbons RJ, SuthersGK, Wilkie AOM, Buckle VJ, HiggsDR. Xlinked α thalassemia/mental retardation (ATR-X) syndrome: Localisation to Xq12-21.31 by X-inactivation and linkage analysis. AmJ Hum Genet. 1992;51:1136-1149.
43. Garrick D, Sharpe JA, Arkell R, et al. Loss of Atrx affects trophoblast development and the pattern of X-inactivation in extraembryonic tissues. PLoS Genet. 2006;2:e58.
44. Muers MR, Sharpe JA, Garrick D, et al. Defining the cause of skewed X-chromosome inactivation in X-linked mental retardation by use of a mouse model. Am J Hum Genet. 2007;80:1138-1149.
45. Gecz J, Pollard H, Gonzalez G, et al. Cloning and expression of the murine homologue of a putative human X-linked nuclear protein gene closely linked to PGK1 in Xq13.3. Hum Mol Genet. 1994;3:39-44.
46. Gibbons RJ, Picketts DJ, Villard L, Higgs DR. Mutations in a putative global transcriptional regulator cause X-linked mental retardation with α-thalassemia (ATR-X syndrome). Cell. 1995;80:837-845.
47. Picketts DJ, Higgs DR, Bachoo S, Blake DJ, Quarrell OWJ, Gibbons RJ. ATRX encodes a novel member of the SNF2 family of proteins: mutations point to a common mechanism underlying the ATR-X syndrome. Hum Mol Genet. 1996;5:1899-1907.
48. Garrick D, Samara V, McDowell TL, et al. A conserved truncated isoform of the ATR-X syndrome protein lacking the SWI/SNF-homology domain. Gene. 2004;326:23-34.
49. Gibbons RJ, Bachoo S, Picketts DJ, et al. Mutations in a transcriptional regulator (hATRX) establish the functional significance of a PHD-like domain. Nat Genet. 1997;17:146-148.
50. Argentaro A, Yang JC, Chapman L, et al. Structural consequences of disease-causing mutations in the ATRX-DNMT3-DNMT3L (ADD) domain of the chromatin-associated protein ATRX. Proc Natl Acad Sci USA. 2007;104:11939-11944.
51. Bienz M. The PHD finger, a nuclear protein-interaction domain. Trends Biochem Sci. 2006;31:35-40.
52. Cardoso C, Lutz Y, Mignon C, et al. ATR-X mutations cause impaired nuclear location and altered DNA binding properties of the XNP/ATR-X protein. JMedGenet. 2000;37:746-751.
53. Picketts DJ, Tastan AO, Higgs DR, Gibbons RJ. Comparison of the human and murine ATRX gene identifies highly conserved, functionally important domains. Mammal Genome. 1998;9:400-403.
54. Carlson M, Laurent BC. The SNF/SWI family of global transcriptional activators. Curr Opin Cell Biol. 1994;6:396-402.
55. Gibbons RJ, Wada T, Fisher C, et al. Mutations in the chromatin associated protein ATRX. Hum Mutat. 2008:29:796-802.
56. Howard MT, Malik N, Anderson CB, Voskuil JL, Atkins JF, Gibbons RJ. Attenuation of an amino-terminal premature stop codon mutation in the ATRX gene by an alternative mode of translational initiation. J Med Genet. 2004;41:951-956.
57. McDowell TL, Gibbons RJ, Sutherland H, et al. Localization of a putative transcriptional regulator (ATRX) at pericentromeric heterochromatin and the short arms of acrocentric chromosomes. Proc Natl Acad Sci USA. 1999;96:13983-13988.
58. Badens C, Lacoste C, Philip N, et al. Mutations in PHD-like domain of the ATRX gene correlate with severe psychomotor impairment and severe urogenital abnormalities in patients with ATRX syndrome. Clin Genet. 2006;70:57-62.
59. Ion A, Telvi L, Chaussain JL, et al. A novel mutation in the putative DMA Helicase XH2 is responsible for male-tofemale sex reversal associated with an atypical form of the ATR-X syndrome. AmJ Hum Genet. 1996;58:1185-1191.
60. Villard L, Toutain A, Lossi A-M, et al. Splicing mutation in the ATR-X gene can lead to a dysmorphic mental retardation phenotype without α-thalassemia. Am J Hum Genet. 1996;58:499-505.
61. Stayton CL, Dabovic B, Gulisano M, Gecz J, Broccoli V, Giovanazzi S et al. Cloning and characterisation of a new human Xq13 gene, encoding a putative helicase. Hum Mol Genet. 1994;3:1957-1964.
62. Berube NG, Smeenk CA, Picketts DJ. Cell cycle-dependent phosphorylation of the ATRX protein correlates with changes in nuclear matrix and chromatin association. Hum Mol Genet. 2000;9:539-547.
63. Xue Y, Gibbons R, Van Z, et al. The ATRX syndrome protein forms a chromatin-remodeling complex with Daxx and localizes in promyelocytic leukemia nuclear bodies. ProcNatl Acad Sci USA. 2003;100:10635-10640.
64. Gibbons RJ, McDowell TL, Raman S, et al.Mutations in ATRX, encoding a SWI/SNF-like protein, cause diverse changes in the pattern of DNA methylation. Nat Genet. 2000;24:368-371.
65. Le Douarin B, Nielsen AL, Gamier JM, et al. A possible involvement of TIF1 alpha and TIF1 beta in the epigenetic control of transcription by nuclear receptors. EMBO J. 1996;15:6701-6715.
66. Kourmpuli N, Sun YM, Van Der Sar S, Singh PB, Brown JP. Epigenetic regulation of mammalian pericentric heterochromatin in vivo by HP1. Biochem Biophys Res Commun. 2005;337:901-907.
67. Nan X, Hou J, Maclean A, et al. Interaction between chromatin proteins MECP2 and ATRX is disrupted by mutations that cause inherited mental retardation. Proc Natl Acad Sci USA. 2007;104:2709-2714.
68. Wysocka J, Swigut T, Xiao H, et al. A PHD finger of NURF couples histone H3 lysine 4 trimethylation with chromatin remodelling. Nature. 2006;442:86-90.
69. Pena PV, Davrazou F, Shi X, et al. Molecular mechanism of histone H3K4me3 recognition by plant homeodomain of ING2. Nature. 2006;442:100-103.
70. Fuks F, BurgersWA, Godin N, Kasai M, Kouzarides T. Dnmt3a binds deacetylases and is recruited by a sequence-specific represser to silence transcription. EMBO J. 2001;20:2536-2544.
71. Tang J, Wu S, Liu H, et al. A novel transcription regulatory complex containing death domain-associated protein and the ATR-X syndrome protein. J Biol Chem. 2004;279:20369-20377.
72. Cardoso C, Timsit S, Villard L, Khrestchatisky M, Fontes M, Colleaux L. Specific interaction between the XNP/ATR-X gene product and the SET domain of the human EZH2 protein. Hum Mol Genet. 1998;7:679-684.
73. Dennis K, Fan T, Geiman T, Van Q, Muegge K. Lsh, a member of the SNF2 family, is required for genome-wide methylation. Genes Dev. 2001;15:2940-2944.
74. Jeddeloh JA, Stokes TL, Richards EJ.Maintenance of genomic methylation requires a SWI2/SNF2-like protein [see comments]. Nat Genet. 1999;22:94-97.
75. Steensma DP, Gibbons RJ, Higgs DR. Acquired α thalassemia in association with myelodysplastic syndrome and other hematologic malignancies. Blood. 2005;105:443-452.
76. Bergren WR, Sturgeon PH. Hemoglobin H: Some Additional Findings. New York: Proceedings of the 7th International Congress in Hematology; 1960:488.
77. White JC, Ellis M, Coleman PN, et al. An unstable haemoglobin associated with some cases of leukaemia. Br J Haematol. 1960;6:171-177.
78. Harris NL, Jaffe ES, Diebold J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol. 1999;17:3835-3849.
79. Higgs DR, Wood WG, Barton C, Weatherall DJ. Clinical features and molecular analysis of acquired hemoglobin H disease. Am J Med. 1983;75:181-191.
80. Bradley TB, Ranney HM. Acquired disorders of hemoglobin. Prog Hematol. 1973;8:77-98.
81. Dibenedetto SP, Russo Mancuso G, Di Cataldo A, Schiliro G. Non inherited hemoglobin anomalies. Haematologica. 1991;76:414-420.
82. Hoyle C, Kaeda J, Leslie J, Luzzatto L. Acquired beta thalassaemia trait in MDS. Br J Haematol. 1991;79:116-117.
83. Weinberg RS, Leibowitz D, Weinblatt ME, Kochen J, Alter BP. Juvenile chronic myelogenous leukaemia: the only example of truly fetal (not fetal-like) erythropoiesis. Br J Haematol. 1990;76:307-310.
84. Old J, Longley J, Wood WG, Clegg JB, Weatherall DJ. Molecular basis for acquired haemoglobin H disease. Nature. 1977;269:524-525.
85. Steensma DP, Porcher JC, Hanson CA, et al. Prevalence of erythrocyte haemoglobinHinclusions in unselected patients with clonal myeloid disorders. Br J Haematol. 2007;139:439-442.
86. Siekmeier R, Bierlich A, Jaross W. Determination of reticulocytes: three methods compared. Clin Chem Lab Med. 2000;38:245-249.
87. Higgs DR, Garrick D, Anguita E, et al.Understanding α-globin gene regulation: aiming to improve the management of thalassemia. Ann NY Acad Sci. 2005;1054:92-102.
88. Kueh YK. Acute lymphoblastic leukemia with brilliant cresyl blue erythrocytic inclusions-acquired hemoglobin H? NEngl J Med. 1982;307:193-194.
89. Higgs DR, Wood WG, Barton C, Weatherall DJ. Clinical features and molecular analysis of acquired HbH disease. Am J Med. 1983;75:181-191.
90. Peters RE, May A, Jacobs A. Increased alpha:non-alpha globin chain synthesis ratios in myelodysplastic syndromes and myeloid leukaemia. J Clin Pathol. 1986;39:1233-1235.
91. Higgs DR. Ham-Wasserman lecture: gene regulation in hematopoiesis: new lessons from thalassemia. Hematology AmSoc Hematol Edu Program. 2004:1-13.
92. Gibbons RJ, Pellagatti A, Garrick D, et al. Identification of acquired somatic mutations in the gene encoding chromatin-remodeling factor ATRX in the alpha-thalassemia myelodysplasia syndrome (ATMDS). Nat Genet. 2003;34:446-449.
93. Steensma DP, Higgs DR, Fisher CA, Gibbons RJ. Acquired somatic ATRX mutations in myelodysplastic syndrome associated with alpha thalassemia (ATMDS) convey a more severe hematologic phenotype than germline ATRX mutations. Blood. 2004;103:2019-2026.
94. Weatherall DJ, Higgs DR, Clegg JB. The molecular pathology of the alpha globin genes. Br J Cancer. 1988;9(Suppl):17-22.
95. Steensma DP, Viprakasit V, Hendrick A, et al. Deletion of the alpha-globin gene cluster as a cause of acquired alphathalassemia in myelodysplastic syndrome. Blood. 2004;103: 1518-1520.
96. Helder J, Deisseroth A. S1 nuclease analysis of α-globin gene expression in preleukemic patients with acquired hemoglobin H disease after transfer to mouse erythroleukemia cells. Proc Natl Acad Sci. USA. 1987;84:2387-2390.
97. Gibbons RJ, Wada T. ATRX and X-linked α-thalassemia mental retardation syndrome. In: Epstein CJ, Erickson RP, Wynshaw-Boris A, eds. Inborn Errors ofDevelopment. Oxford: Oxford University Press; 2004:747-757.
98. Nelson ME, Thurmes PJ, Hoyer JD, Steensma DP. A novel 5ʹ ATRX mutation with splicing consequences in acquired alpha thalassemia-myelodysplastic syndrome. Haematologica. 2005;90:1463-1470.
99. Costa DB, Fisher CA, Miller KB, et al. A novel mutation in the last exon of ATRX in a patient with alpha-thalassemia myelodysplastic syndrome. Eur JHaematol. 2006;76:432-435, 53.
100. Haas PS, Schwabe M, Fisher C, et al. Two novel somatic mutations of the ATRX gene in female patients with acquired alpha thalassemia in myelodysplastic syndrome (ATMDS). Blood. 2006;108:A1765.
101. Gibbons RJ, Higgs DR. The Molecular-Clinical Spectrum of the ATR-X Syndrome. Am JMed Genet. 2000;97:204-212.
102. Steensma DP, Allen S, Gibbons RJ, Fisher CA, Higgs DR. Abstract 3606: A novel splicing mutation in the gene encoding the chromatin-associated factor ATRX associated with acquired hemoglobin H disease in myelodysplastic syndrome (ATMDS). Blood. 2004;104(11):A3606.
103. Steensma DP, Bennett JM. The myelodysplastic syndromes: diagnosis and treatment.Mayo Clin Proc. 2006;81:104-130.
104. Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet. 2002;3:415-428.
105. Leone G, Teofili L, Voso MT, Lubbert M. DMA methylation and demethylating drugs in myelodysplastic syndromes and secondary leukemias. Haematologica. 2002;87:1324-1341.
106. Kantarjian H, Issa JP, Rpsenfeld CS, et al. Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study. Cancer. 2006;106: 1794-1803.
107. Silverman LR, Demakos EP, Peterson BL, et al. Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B. J ClinOncol. 2002;20:2429-2440.
108. Silverman LR. DMA methyltransferase inhibitors in myelodysplastic syndrome. Best Pract Res Clin Haematol. 2004;17:585-594.
109. Lindor NM, Valdes MG, Wick M, Thibodeau SN, Jalal S. De novo 16p deletion:ATR-16 syndrome. Am J Med Genet. 1997;72:451-454.
110. Fei YJ, Liu JC, Walker ELDI, Huisman THJ. A new gene deletion involving the α2-, α1-, and θ1-globin genes in a Black family with HbH disease. Am J Hematol. 1992;39:299-303.
111. Felice AE, Cleek MP, McKie K, McKie V, Huisman THJ. The rare α-thalassemia-1 of Blacks is a ζα-thalassemia-1 associated with deletion of all α-and ζ-globin genes. Blood. 1984;63:1253-1257.
112. Rack KA, Harris PC, MacCarthy AB, et al. Characterization of three de novo derivative chromosomes 16 by 'reverse chromosome painting' and molecular analysis. Am J Hum Genet. 1993;52:987-997.
113. Rönich P, Kleihauer E. Alpha-thalassamie mit HbH und Hb Bart's in einer deutschen Familie. Klin Wochenschrift. 1967;45:S1193-1200.
114. Gallego MS, Zelaya G, Feliu AS, et al. ATR-16 due to a de novo complex rearrangement of chromosome 16. Hemoglobin. 2005;29:141-150.
115. Gibson WT, Harvard C, Qiao Y, Somerville MJ, Lewis MES, Rajcan-Separovic E. Phenotype-genotype characterization of alpha-thalassemia mental retardation syndrome due to isolated monosomy of 16p13.3. Am JMed Genet. 2008;146A:225-232.
116. Kamei M, Ades LC, Eyre HJ, Callen DF, Campbell HD. SOLH, a human homologue of the Drosophila melanogaster small optic lobes gene is deleted in ATR-16 syndrome. Appl Genom Proteom. 2002;1:65-71.
117. Villegas A, Ropero P, Gonzalez FA, Anguita E, Espinos D. The thalassemia syndromes: molecular characterization in the Spanish population. Hemoglobin. 2001;25:273-283.
118. Hjelle B, Charache S, Phillips JAR. Hemoglobin H disaese and multiple congenital anomalies in a child of northern European origin. Am J Hematol. 1982;13:319-322.
119. Dallman PR. The red cell. In: Dallman PR, ed. Blood and Blood-forming Tissues. New York: Appleton-Century-Crofts; 1977:1109-1113.